Peripheral Artery Disease Market Forecast: What to Expect by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Is The Projected Market Size Of The Peripheral Artery Disease Market By 2029?

The peripheral artery disease market size has demonstrated strong growth in recent years. This market is expected to expand from $4.31 billion in 2024 to $4.62 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.1%. The growth observed in the past can be linked to factors like the rising prevalence of risk factors, an expanding aging population, developments in clinical research and evidence-based medicine, the introduction of awareness and screening programs, and various government healthcare initiatives.

The peripheral artery disease market size is anticipated to experience substantial growth in the upcoming years, with projections indicating it will reach $6.2 billion in 2029, exhibiting a compound annual growth rate (CAGR) of 7.6%. This expansion during the forecast period is largely due to an increased emphasis on patient-centric care, progress in minimally invasive procedures, the adoption of digital health and remote monitoring technologies, new regenerative medicine approaches, and the development of targeted drug therapies. Key trends expected over this period encompass health equity initiatives, the integration of wearable devices, an expansion of home-based rehabilitation services, the incorporation of patient-reported outcomes (pros), and a discernible shift towards outpatient settings for care.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

Which Industry Drivers Are Expected To Accelerate The Peripheral Artery Disease Market From 2025 To 2029?

The increasing prevalence of peripheral artery diseases is anticipated to drive the expansion of the peripheral artery disease market in the future. Peripheral artery disease involves the narrowing or obstruction of arteries outside the heart, commonly in the legs, which leads to diminished blood flow and potential health complications. Treatments for peripheral artery disease work to lessen symptoms, improve mobility, and reduce the risk of severe issues, ultimately enhancing patients’ overall well-being. For instance, in June 2023, the American Heart Association, a US-based nonprofit organization, estimated that between 7 to 12 million individuals in the United States and 200 million people globally are impacted by this condition. Thus, the escalating prevalence of peripheral artery diseases is fostering the growth of the peripheral artery disease market.

What Are The Segment Types Shaping The Peripheral Artery Disease Market?

The peripheral artery diseasemarket covered in this report is segmented –

1) By Type: Peripheral Angioplasty Balloons; Peripheral Stents; Peripheral Catheters; Inferior Vena Cava (IVC) Filters; Plaque Modification Devices; Hemodynamic Flow Alteration Devices; Peripheral Accessories

2) By Drugs: Lipid-Lowering Drugs; Blood Pressure Lowering Drugs; Glucose Regulating Drugs; Blood Clot Preventing Drugs; Inotropes; Thrombolytics Agents; Anti-Inflammatory Agents

3) By Route of Administration: Oral; Parenteral; Other Routes of Administration

4) By End Users: Hospitals; Specialty Clinics; Other End Users

Subsegments:

1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons; Non-Drug-Eluting Balloons; Scoring Balloons; Cutting Balloons

2) By Peripheral Stents: Drug-Eluting Stents; Bare Metal Stents; Covered Stents

3) By Peripheral Catheters: Sheath Introducers; Guidewires; Diagnostic Catheters; Delivery Catheters

4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters; Permanent IVC Filters

5) By Plaque Modification Devices: Atherectomy Devices; Laser Atherectomy Devices; Rotational Atherectomy Devices

6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices; Flow Restriction Devices

7) By Peripheral Accessories: Diagnostic Imaging Accessories; Accessory Kits for Interventional Procedures; Support Devices

How Are Trends Influencing The Peripheral Artery Disease Market?

A significant trend observed in the peripheral artery disease market is the increasing adoption of technological advancements. Leading firms within the peripheral artery disease sector are implementing cutting-edge surgical procedures to maintain their competitive edge. For example, Genesis MedTech Group, a medical device company based in Singapore, launched the chocolate touch paclitaxel DCB catheter in November 2022. This percutaneous transluminal angioplasty (PTA) catheter is designed for individuals suffering from superficial femoral artery and popliteal artery disease. This Chocolate Touch drug-coated balloon represents the initial and sole balloon catheter within the device, integrating therapeutic agent delivery with an advanced angioplasty platform specifically for peripheral artery disease management. It incorporates pillow-shaped structures coated with a therapeutic chemical, which expand incrementally to provide an alternative treatment option to conventional drug-coated balloon angioplasty for those with peripheral artery disease. Consequently, this design enhances the balloon’s surface area, enabling superior medication absorption into the vessel wall and negating the necessity for permanent implants.

Which Leading Players Are Enhancing Their Peripheral Artery Disease Market Presence Worldwide?

Major companies operating in the peripheral artery disease market include Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Which Geographies Are Emerging As Strong Markets For The Peripheral Artery Disease Industry?

North America was the largest region in the peripheral artery disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Peripheral Artery Disease Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12068&type=smp

Browse Through More Reports Similar to the Global Peripheral Artery Disease Market 2025, By The Business Research Company

Repair And Maintenance Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/repair-and-maintenance-global-market-report

Concrete Restoration Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/concrete-restoration-global-market-report

Concrete Admixtures Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/concrete-admixtures-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795